Denosumab osteonecrosis of the mandible: A new entity?A case report

Journal of Cranio-Maxillofacial Surgery

Volumn 41, Issue 4, 2013, Pages

  Pichardo, Sarina E C ^a   Kuypers, Sophie C C ^a   Van Merkesteyn, J P Richard ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bisphosphonates; Denosumab; Mandible; Osteomyelitis; Osteonecrosis

Indexed keywords

DENOSUMAB; METRONIDAZOLE; PENICILLIN DERIVATIVE; ZOLEDRONIC ACID;

ACTINOMYCOSIS; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CASE REPORT; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; HUMAN; JAW OSTEONECROSIS; MALE; NEUROLOGIC DISEASE; OSSIFICATION; PHASE 3 CLINICAL TRIAL (TOPIC); PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); STREPTOCOCCUS CONSTELLATUS; SURGICAL DRAINAGE; TONGUE DISEASE; TRANSURETHRAL RESECTION;

ABSCESS; ACTINOMYCOSIS; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; BONE DENSITY CONSERVATION AGENTS; BONE NEOPLASMS; BRAIN NEOPLASMS; CUTANEOUS FISTULA; FATAL OUTCOME; FUSOBACTERIUM INFECTIONS; HUMANS; MALE; MANDIBULAR DISEASES; ORAL FISTULA; OSTEONECROSIS; PROSTATIC NEOPLASMS; RANK LIGAND; STREPTOCOCCAL INFECTIONS;

EID: 84876677602     PISSN: 10105182     EISSN: 18784119     Source Type: Journal    
DOI: 10.1016/j.jcms.2012.10.014     Document Type: Article

References (22)

1. T.L. Aghaloo, A.L. Felsenfeld, and S. Tetradis Osteonecrosis of the jaw in a patient on denosumab J Oral Maxillofac Surg 68 2010 959 963
2. K. Alons, S.C. Kuijpers, E. Jong de, and J.P.R. Merkesteyn Treating low and median potent bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis; report of 7 cases Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 107 2 2009 e1 e7
3. C. Cooper, G. Campion, and L.J. Melton III Hip fractures in the elderly: a worldwide projection Osteoporos Int 2 6 1992 285 289
4. S.R. Cummings, J. San Martin, M.R. McClung, E.S. Siris, R. Eastell, and I.R. Reid Denosumab for prevention of fractures in postmenopausal women with osteoporosis N Engl J Med 361 8 20 Aug 2009 756 765 Erratum in: N Engl J Med 361(19): 1914, Nov 5 2009
5. K. Fizazi, M. Carducci, M. Smith, R. Damião, J. Brown, and L. Karsh Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study Lancet 377 5 March 2011 813 822
6. V. Fusco, C. Galassi, A. Berruti, L. Ciuffreda, C. Ortega, and G. Ciccone Osteonecrosis of the jaw after zoledronic acid and denosumab treatment. Comment on J Clin Oncol 29 17 Jun 10 2011 e521 e522 author reply e523-e524
7. D.H. Henry, L. Costa, F. Goldwasser, V. Hirsh, V. Hungria, and J. Prausova J Clin Oncol 29 2011 1125 1132
8. G.N. Hortobagyi, R.L. Theriault, L. Porter, D. Blayney, A. Lipton, and C. Sinoff Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases: Protocol 19 Aredia Breast Cancer Study Group N Engl J Med 335 1996 1785 1791
9. R. Hultborn, S. Gundersen, S. Ryden, E. Holmberg, J. Carstensen, and U.B. Wallgren Efficacy of pamidronate in breast cancer with bone metastases: a randomized, double-blind placebo-controlled multicenter study Anticancer Res 19 1999 3383 3392
10. D.L. Kendler, C. Roux, C.L. Benhamou, J.P. Brown, M. Lillestol, and S. Siddhanti Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy J Bone Miner Res 25 1 Jan 2010 72 81
11. N.E. Lane Epidemiology, etiology and diagnosis of osteoporosis Am J Obstet Gynecol 194 2006 S3 S11
12. E.M. Lewiecki, P.D. Miller, M.R. Mcclung, S.B. Cohen, M.A. Bolognese, Y. Liu AMG 162 Bone Loss Study Group J Bone Miner Res 22 12 Dec 2007 1832 1841
13. E.M. Lewiecki Denosumab-an emerging treatment for postmenopausal osteoporosis Expert Opin Biol Ther 10 3 2010 467 476
14. A. Lipton, G.G. Steger, J. Figueroa, C. Alvarado, P. Solal-Celigny, and J.J. Body Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases J Clin Oncol 25 28 Oct 1 2007 4431 4437
15. T. Mavrokokki, A. Cheng, B. Stein, and A. Goss Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia J Oral Maxillofac Surg 65 2007 415 423
16. S. Papapoulos, R. Chapurlat, C. Libanati, M. Luisa Brandi, J.P. Brown, and E. Czerwinski Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension J Bone Miner Res 27 3 2012 694 701
17. R. Rizzoli, N. Burlet, D. Cahall, P.D. Delmas, E.F. Eriksen, and D. Felsenberg Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis Bone 42 5 2008 841 847
18. F. Saad, J.E. Brown, C. van Poznak, T. Ibrahim, S.M. Stemmer, and A.T. Stopeck Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases Ann Oncol 23 5 10th May 2012 1341 1347
19. M.R. Smith, B. Egerdie, N. Hernández Toriz, R. Feldman, T.L. Tammela, and F. Saad Denosumab in men receiving androgen-deprivation therapy for prostate cancer N Engl J Med 361 2009 745 755
20. M.R. Smith, F. Saad, R. Coleman, N. Shore, N. Fizazi, and B. Tombal Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomized, placebo-controlled trial Lancet 379 7 January 2012 39 46
21. R.L. Theriault, A. Lipton, G.N. Hortobagyi, R. Leff, S. Glück, and J.F. Stewart Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial: Protocol 18 Aredia Breast Cancer Study Group J Clin Oncol 17 1999 846 854
22. A. Wardley, N. Davidson, P. Barrett-Lee, A. Hong, J. Mansi, and D. Dodwell Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration Br J Cancer 92 2005 1869 1876